N E W S R O U N D
Selected press reports compiled by the ESO Download full article
breast cancer
No one told me I had a choice
The right of every patient to play a full role in decisions relating to their treatment remains more of an aspiration than a reality, according to a recent survey of breast cancer patients. For the [more]
N E W S R O U N D
Selected press reports compiled by the ESO Download full article
Record-breaking stamp raises sticky questions
Concern that vital research is being side-lined for lack of funds prompted US breast cancer surgeon Ernie Bodai to campaign for a special fundraising stamp. Despite the 6-cent mark-up, it has outsold all previous commemorative [more]
What’s brave about having cancer?
On September 1st, exactly six years after being told she had only six months to live, Jane Tomlinson completed a gruelling 6,780-km bike trek across America. Before setting out, she talked about why she refuses [more]
Does trastuzumab increase the risk of isolated CNS metastases in patients with breast cancer?
Research shows that brain metastasis of breast cancer may occur more often in women with HER2 overexpression. These patients require more aggressive surveillance to identify disease earlier, and new therapies are needed that can overcome [more]
PHARE: shining a light for academic research in Europe
Clinical research activity may be plummeting in the rest of Europe, but in France they’re determined to substantially increase the numbers of hospitals and patients involved in clinical trials starting with a strategic trial [more]
Beyond the Herceptin hype
Herceptin may turn out to be the biggest advance in treating breast cancer since tamoxifen. But if we are to prevent soaring drugs bills eating up our health budgets or barring Europe’s poorer patients from [more]
NEWSROUND
Selected press reports complied by the ESO Cancer Media Centre Download full article
When clinical trials are compromised
Advocates for early access to unproven treatments may believe they are helping patients, but their actions can put current patients at risk and deny future patients the knowledge they need to make evidence-based treatment decisions, [more]
Hope or hype?
Decades of experience have taught us to guard against the temptation to trumpet early impressive results as breakthroughs. Yet some of the comments over the promising results from trials testing Herceptin (trastuzumab) in early-stage breast [more]
Coming out for breast cancer country by country
Walks to raise awareness of breast cancer are established traditions in many countries. But in many more, breast cancer remains hidden from public and political agendas. Avon’s Walk Around the World helped connect everyone fighting [more]
NEWSROUND
Selected press reports compiled by the ESO Cancer Media Centre Download full article